Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Eliquis 2.5mg°


Not recommended
Safety has not been established

Contraindicated
Eliquis 2.5mg° :
Type Medicine Withdrawn
Originator B
Agent Droguerie Fattal
Distributor Droguerie Fattal
Laboratory Pfizer
Responsible Party Bristol Myers Squibb/ Pfizer EEIG
Origin UK
Manufacturer Bristol-Myers Squibb SRL
Origin Italy
ATC B01AF02

Your comment will appear shortly after approval

Eliquis 2.5mg° :

Revision Date : 15/04/2016


Effect Frequency
Administration site haemorrhage Uncommon
Allergic oedema Uncommon
Anaphylaxis Uncommon
Cerebral haemorrhage Uncommon
Conjunctival haemorrhage Common
Contusion Common
Epistaxis (Nasal bleeding) Common
Eye haemorrhage Common
Gastroduodenal haemorrhage Common
Gingival bleeding (Gingival hemorrhage) Common
Haematochezia (Hematochezia) Uncommon
Haematoma Common
Haematuria (Hematuria) Common
Haemoptysis Uncommon
Haemorrhage Common
Haemorrhoidal haemorrhage Uncommon
Hypersensitivity Uncommon
Incision site haemorrhage Uncommon
Intra-abdominal haemorrhage Uncommon
Mouth haemorrhage Uncommon
Occult blood positive Uncommon
Post procedural haemorrhage Uncommon
Pruritus Uncommon
Rectal haemorrhage Common
Respiratory tract haemorrhage Rare
Retroperitoneal haemorrhage Rare
Skin Eruption Uncommon
Traumatic haemorrhage Uncommon
Urogenital haemorrhage (Urogenital bleeding) Uncommon
Vaginal haemorrhage Uncommon

Different Units By MoH Code

Eliquis 2.5mg°  MoH 8221 :
Form Tablet, Film-Coated
Packaging Blisters (Al/PVC/PVDC)
Package Size Box of 60
Strength 2.5mg
Storage Condition <30°C None
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 138214/1
Submission date 01/01/2014
Registration Year 2015
Withdrawn Date 05/01/2021


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info